Given we have demonstrated here that GAS can drive a CD1a-autoreactive effector T cell response, we next tested whether individuals with plaque psoriasis have altered frequency and phenotype of GAS-responsive T cells. The gene discussed is CD1A; the disease is psoriasis vulgaris.